(Q35993280)

11 August 2017

Thyroid dysfunction can predict response to immunotherapy with interleukin-2 and interferon-2 alpha (English)

1 reference

11 August 2017

1 reference

I Reid

1

1 reference

11 August 2017

I Sharpe

2

1 reference

11 August 2017

J McDevitt

3

1 reference

11 August 2017

W Maxwell

4

1 reference

11 August 2017

R Emmons

5

1 reference

11 August 2017

W A Tanner

6

1 reference

11 August 2017

J R Monson

7

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 November 1991

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

64

1 reference

11 August 2017

915-918

1 reference

11 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1991.426

11 August 2017

0 references

cites work

The immunopathology of sequential tumor biopsies in patients treated with interleukin-2. Correlation of response with T-cell infiltration and HLA-DR expression.

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977462

Clinical effects and toxicity of interleukin-2 in patients with cancer

2 October 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977462

Thyroiditis after treatment with interleukin-2 and interferon alpha-2a

2 October 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977462

High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findings

2 October 2017

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells

1 reference

12 December 2020

Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon

1 reference

12 December 2020

Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer

1 reference

12 December 2020

Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets

1 reference

12 December 2020

Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity

1 reference

12 December 2020

Interferon-gamma induces HLA-DR expression by thyroid epithelium

1 reference

12 December 2020

An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1991.426

1 reference

11 August 2017

1 reference

11 August 2017

1 reference